Resource library

This report by the University of Sydney School of Pharmacy informed the development of the National standard for labelling dispensed medicines. The report summarises qualitative user testing of prototype labels with consumers in Australia. Subsequent stakeholder consultations were undertaken to finalise the Standard. 

The Pharmaceutical Benefits Scheme Hospital Medication Chart (PBS HMC) enables the prescribing, administering, supply and claiming of eligible PBS and non-PBS medicines without the need to issue a separate prescription.

In 2019, Professor Lynne Emmerton led the review of name similarity for:

• Monoclonal antibodies (MABs) (commonly ending in the suffix ‘mab’)
• Tyrosine kinase (factor) inhibitors (TKIs) (commonly ending in the suffix ‘nib’).

This included the theoretical risk of confusion within these classes of medicines in clinical practice, including the similarity in clinical indication, with a view to producing a specialised list of medicines. The results of this review can be found in this publication.

This report outline the findings and recommendations from the National Standard Medication Chart (NSMC) national audit conducted in 2018.

A safety statement recommending that established metered dose inhalers are prescribed and communicated by the metered dose.

This alert provides more information in regard to concentrated intravenous potassium chloride. Inappropriate injection of undiluted intravenous potassium chloride has been implicated in fatalities in Australia and overseas.

Safe and high-quality care for patients with cognitive impairment or at risk of delirium in acute health services

Consultation on this discussion paper closed 5 July 2019.

The clinician survey is part of the end-of-life care audit toolkit and is made up of 31 questions designed to be undertaken across four demographics; consultants, junior doctors, nurses and allied health professionals.

The purpose of this report is to outline the processes used by the Commission to obtain feedback from the primary health care sector and a summary of the feedback that was received.

Adoption and utilisation of SNOMED CT-AU and AMT: Safe use of medicines – allergies and adverse drug reactions

The end-of-life care audit tool was developed to give hospitals the ability to compile data associated with the delivery of end-of-life care in a manageable and uniform way. Having the capacity to collect and analyse this data allows hospitals to review how care is being delivered and identify opportunities for better alignment with the Consensus Statement, and improvement of end-of-life care in general.